Edesa Biotech
EDSA
25 hedge funds and large institutions have $2.03M invested in Edesa Biotech in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 5 closing their positions.
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
14% more funds holding
Funds holding: 22 → 25 (+3)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
0.03% less ownership
Funds ownership: 0.42% → 0.38% (-0.03%)
29% less capital invested
Capital invested by funds: $2.85M → $2.03M (-$819K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$234K |
| 2 |
Renaissance Technologies
New York
|
+$226K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$103K |
| 4 |
Two Sigma Investments
New York
|
+$86.2K |
| 5 |
State Street
Boston,
Massachusetts
|
+$61.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$619K |
| 2 |
1WA
180 Wealth Advisors
Federal Way,
Washington
|
-$156K |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$100K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$20.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$17.4K |
EDSA Hedge Fund Activity: Q4 2021 in Review
25 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q4 2021, worth a combined $2.03M — down 29% from $2.85M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new EDSA positions and 5 closed out — a net gain of 3 holders — while 4 added to existing stakes and 4 trimmed.
The largest buyer was Dimensional Fund Advisors, adding an estimated $234K. The largest seller was Virtu Financial, cutting an estimated $619K.
- 25 institutional investors held Edesa Biotech (EDSA) as of Q4 2021, up from 22 in Q3 2021.
- Funds reported $2.03M of Edesa Biotech stock for Q4 2021, down 29% quarter-over-quarter.
- 8 funds opened new Edesa Biotech positions in Q4 2021 and 5 closed out, a net change of +3 holders.
- The largest Edesa Biotech buyer in Q4 2021 was Dimensional Fund Advisors, an estimated $234K added.
- The largest Edesa Biotech seller in Q4 2021 was Virtu Financial, an estimated $619K sold.
Based on aggregated 13F filings for Q4 2021.